Monday, January 18, 2021
Home Latest Pharma-News

Latest Pharma-News

Initiation Of First Large-Scale Registry :To Evaluate Real-World Lipid Management And The Effectiveness Of PCSK9 Inhibitors

Nov. 15, 2019: Amgen and the Duke Clinical Research Institute (DCRI) announced plans to initiate the Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 inhibitors (cvMOBIUS) study in order...

Single, subanesthetic-dose of ketamine infusion relatively free of side effects for patients with treatment-resistant depression

Nov 15, 2019: NIH researchers found that a single, subanesthetic-dose of ketamine infusion was relatively free of side effects...

New Novartis medicine Adakveo® (crizanlizumab) approved by FDA for the treatment of individuals living with sickle cell disease

Nov 15, 2019: FDA approved Novartis's Adakveo (crizanlizumab-tmca) for the treatment to...

BMS and Pfizer to start a new randamized controlled trial accessing the impact of atrial fibrillation screening on health outcomes in older individuals

Nov 16, 2019: PRINCETON, N.J. and Bristol-Myers Squibb-Pfizer Alliance announced the initiation of a new randomized controlled trial (GUARD-AF) for undiagnosed...

FDA approves Talicia To Treat bacterial infection Linked To Stomach Cancer

Nov 16, 2019: Bacterial infection affects millions of American adults in a year and is one of the strongest known causes of...

Zydus Cadila gets tentative approval from USFDA for Apremilast tablets for the treatment of psoriatic arthritis

Nov 16, 2019: USFDA approved Zydus Cadila’s Apremilast tablets for the treatment of psoriatic arthritis and moderate to severe plaque psoriasis. The US...

New antibacterial drug approved by FDA to treat complicated urinary tract infections for antimicrobial resistance

Nov 14, 2019: The U.S. Food and Drug Administration (FDA)  approved Shionogi’s Fetroja (cefiderocol), an antibacterial drug used for the...

Most Read

GSK presents positive efficacy data of dostarlimab at ASCO Gastrointestinal Cancers Symposium

January 16, 2021: "GlaxoSmithKline (GSK) plc announced updated data from GARNET cohort F evaluating dostarlimab in mismatch repair-deficient (dMMR) non-endometrial advanced solid...

Bharat Biotech signs agreement with Precisa Medicamentos for supply of ‘COVAXIN™’ to Brazil

January 12, 2020: "Bharat Biotech announced that it has signed an agreement with Precisa Medicamentos for the supplies of COVAXIN™ to Brazil.

What Is a Blockbuster Drug?

What Is a Blockbuster Drug? "Blockbuster drugs are those that generate at least $1 billion of revenue per...

Boehringer Ingelheim and Enara Bio join forces to discover Cancer Immunotherapies

January 12th, 2021: Boehringer Ingelheim and Enara Bio announced that they have entered into a strategic collaboration and licensing agreement to research...